Capacitabine

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bortezomib 2 mg/ 3.5 mg. It belongs toalyophilised injections finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes brinzolamide. It belongs to antiglaucoma apis products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes buserelin acetate. It belongs to infertility apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes buserelin acetate injection (7 mg / 7 ml). It belongs to gynaecology finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes calcipotriol. It belongs to antiparathyroid & antipsoriatic apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes calcitriol. It belongs to antiosteoporosis apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes capacitabine tablets 500 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes carboplatin injection 150 mg/ 450 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin. It belongs to antifungal apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin 50 mg/70 mg - under development. It belongs to antifungal finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes caspofungin acetate. It belongs to antifungal apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefdinir. It belongs to cephalosporins apis products category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.